154 related articles for article (PubMed ID: 30523770)
21. Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety.
Zakharenko A; Khomenko T; Zhukova S; Koval O; Zakharova O; Anarbaev R; Lebedeva N; Korchagina D; Komarova N; Vasiliev V; Reynisson J; Volcho K; Salakhutdinov N; Lavrik O
Bioorg Med Chem; 2015 May; 23(9):2044-52. PubMed ID: 25819333
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and Biological Activities of 11- and 12-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB and Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.
Yang H; Qin C; Wu M; Wang FT; Wang W; Agama K; Pommier Y; Hu DX; An LK
ChemMedChem; 2023 May; 18(10):e202200593. PubMed ID: 36932053
[TBL] [Abstract][Full Text] [Related]
23. Tyrosyl-DNA Phosphodiesterase 1 Inhibitors: Usnic Acid Enamines Enhance the Cytotoxic Effect of Camptothecin.
Zakharenko A; Luzina O; Koval O; Nilov D; Gushchina I; Dyrkheeva N; Švedas V; Salakhutdinov N; Lavrik O
J Nat Prod; 2016 Nov; 79(11):2961-2967. PubMed ID: 27933897
[TBL] [Abstract][Full Text] [Related]
24. New Dual Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 and 2 Based on Deoxycholic Acid: Design, Synthesis, Cytotoxicity, and Molecular Modeling.
Salomatina OV; Kornienko TE; Zakharenko AL; Komarova NI; Achara C; Reynisson J; Salakhutdinov NF; Lavrik OI; Volcho KP
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338326
[TBL] [Abstract][Full Text] [Related]
25. Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.
Zhang XR; Wang HW; Tang WL; Zhang Y; Yang H; Hu DX; Ravji A; Marchand C; Kiselev E; Ofori-Atta K; Agama K; Pommier Y; An LK
J Med Chem; 2018 Nov; 61(22):9908-9930. PubMed ID: 30336023
[TBL] [Abstract][Full Text] [Related]
26. Monoterpene substituted thiazolidin-4-ones as novel TDP1 inhibitors: Synthesis, biological evaluation and docking.
Ivankin DI; Dyrkheeva NS; Zakharenko AL; Ilina ES; Zarkov TO; Reynisson J; Luzina OA; Volcho KP; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem Lett; 2022 Oct; 73():128909. PubMed ID: 35907608
[TBL] [Abstract][Full Text] [Related]
27. Identification of a ligand binding hot spot and structural motifs replicating aspects of tyrosyl-DNA phosphodiesterase I (TDP1) phosphoryl recognition by crystallographic fragment cocktail screening.
Lountos GT; Zhao XZ; Kiselev E; Tropea JE; Needle D; Pommier Y; Burke TR; Waugh DS
Nucleic Acids Res; 2019 Nov; 47(19):10134-10150. PubMed ID: 31199869
[TBL] [Abstract][Full Text] [Related]
28. New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties.
Khomenko T; Zakharenko A; Odarchenko T; Arabshahi HJ; Sannikova V; Zakharova O; Korchagina D; Reynisson J; Volcho K; Salakhutdinov N; Lavrik O
Bioorg Med Chem; 2016 Nov; 24(21):5573-5581. PubMed ID: 27658793
[TBL] [Abstract][Full Text] [Related]
29. Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane Moieties.
Kovaleva K; Yarovaya O; Ponomarev K; Cheresiz S; Azimirad A; Chernyshova I; Zakharenko A; Konev V; Khlebnikova T; Mozhaytsev E; Suslov E; Nilov D; Švedas V; Pokrovsky A; Lavrik O; Salakhutdinov N
Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34062881
[TBL] [Abstract][Full Text] [Related]
30. Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy.
Komarova AO; Drenichev MS; Dyrkheeva NS; Kulikova IV; Oslovsky VE; Zakharova OD; Zakharenko AL; Mikhailov SN; Lavrik OI
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1415-1429. PubMed ID: 30191738
[TBL] [Abstract][Full Text] [Related]
31. Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.
Salomatina OV; Popadyuk II; Zakharenko AL; Zakharova OD; Fadeev DS; Komarova NI; Reynisson J; Arabshahi HJ; Chand R; Volcho KP; Salakhutdinov NF; Lavrik OI
Molecules; 2018 Mar; 23(3):. PubMed ID: 29562592
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of the Antitumor and Antimetastatic Effect of Topotecan and Normalization of Blood Counts in Mice with Lewis Carcinoma by Tdp1 Inhibitors-New Usnic Acid Derivatives.
Kornienko TE; Chepanova AA; Zakharenko AL; Filimonov AS; Luzina OA; Dyrkheeva NS; Nikolin VP; Popova NA; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279210
[TBL] [Abstract][Full Text] [Related]
33. 5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA phosphodiesterase I.
Sirivolu VR; Vernekar SK; Marchand C; Naumova A; Chergui A; Renaud A; Stephen AG; Chen F; Sham YY; Pommier Y; Wang Z
J Med Chem; 2012 Oct; 55(20):8671-84. PubMed ID: 23006064
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors.
Lv PC; Agama K; Marchand C; Pommier Y; Cushman M
J Med Chem; 2014 May; 57(10):4324-36. PubMed ID: 24800942
[TBL] [Abstract][Full Text] [Related]
35. Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures.
Davies DR; Interthal H; Champoux JJ; Hol WG
J Mol Biol; 2002 Dec; 324(5):917-32. PubMed ID: 12470949
[TBL] [Abstract][Full Text] [Related]
36. Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models.
Zakharenko AL; Luzina OA; Sokolov DN; Kaledin VI; Nikolin VP; Popova NA; Patel J; Zakharova OD; Chepanova AA; Zafar A; Reynisson J; Leung E; Leung IKH; Volcho KP; Salakhutdinov NF; Lavrik OI
Eur J Med Chem; 2019 Jan; 161():581-593. PubMed ID: 30396105
[TBL] [Abstract][Full Text] [Related]
37. The Lipophilic Purine Nucleoside-Tdp1 Inhibitor-Enhances DNA Damage Induced by Topotecan In Vitro and Potentiates the Antitumor Effect of Topotecan In Vivo.
Chernyshova IA; Zakharenko AL; Kurochkin NN; Dyrkheeva NS; Kornienko TE; Popova NA; Nikolin VP; Ilina ES; Zharkov TD; Kupryushkin MS; Oslovsky VE; Drenichev MS; Lavrik OI
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615517
[TBL] [Abstract][Full Text] [Related]
38. Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy.
Dexheimer TS; Antony S; Marchand C; Pommier Y
Anticancer Agents Med Chem; 2008 May; 8(4):381-9. PubMed ID: 18473723
[TBL] [Abstract][Full Text] [Related]
39. Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors.
Huang SN; Pommier Y; Marchand C
Expert Opin Ther Pat; 2011 Sep; 21(9):1285-92. PubMed ID: 21843105
[TBL] [Abstract][Full Text] [Related]
40. Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment.
Beretta GL; Cossa G; Gatti L; Zunino F; Perego P
Curr Med Chem; 2010; 17(15):1500-8. PubMed ID: 20166932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]